
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sirolimus
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
R3 Vascular Begins ELITE-BTK Trial for PAD Using MAGNITUDE Scaffold
Details : The Magnitude® is a sirolimus-eluting bioresorbable scaffold by R3 vascular. It is a vascular implant designed for below-the-knee peripheral artery disease (PAD).
Product Name : Magnitude
Product Type : Antibiotic
Upfront Cash : Inapplicable
April 22, 2025
Lead Product(s) : Sirolimus
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
